Canada’s main stock index gained more than 330 points on Monday, helped by gains in the technology sector, while U.S. markets also rose.

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

Oil prices are down, and stocks are up Monday, though such moves have been quick to reverse since the war in Iran began.

Political analyst Lori Turnbull on the increased significance of Canada’s diplomatic relationship with the U.K. as trade ...